Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (80)

2015

  1. Actualización terapéutica en la hepatitis C

    Revista Espanola de Quimioterapia, Vol. 28, pp. 48-51

2014

  1. Need for infliximab dose intensification in Crohn's disease and ulcerative colitis

    World Journal of Gastroenterology, pp. 9170-9177

2012

  1. Adalimumab reversed a severe lymphopenia in a patient with Crohn's disease

    Journal of Crohn's and Colitis, Vol. 6, Núm. 4, pp. 488-491

  2. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma

    Oncology, Vol. 82, Núm. 1, pp. 35-40

  3. Relation of IL28b gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease

    PLoS ONE, Vol. 7, Núm. 5

2011

  1. Analysis of the rel polymorphism rs13031237 in autoimmune diseases

    Annals of the Rheumatic Diseases

2010

  1. CD40: Novel association with crohn's disease and replication in multiple sclerosis susceptibility

    PLoS ONE, Vol. 5, Núm. 7, pp. 1-4

  2. High prevalence of viable mycobacterium avium subspecies paratuberculosis in crohn's disease

    World Journal of Gastroenterology, Vol. 16, Núm. 36, pp. 4558-4563

  3. STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility

    Genes and Immunity, Vol. 11, Núm. 3, pp. 264-268

  4. Study of chromosomal region 5p13.1 in Crohn's disease, ulcerative colitis, and rheumatoid arthritis

    Human Immunology, Vol. 71, Núm. 8, pp. 826-828

2009

  1. Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility

    Genes and Immunity, Vol. 10, Núm. 7, pp. 631-635

  2. FcRL3 gene promoter variant is associated with peripheral arthritis in Crohn's disease

    Inflammatory Bowel Diseases, Vol. 15, Núm. 9, pp. 1351-1357

  3. Influence of psychological distress on characteristics of symptoms in patients with GERD: The role of IBS comorbidity

    Digestive Diseases and Sciences, Vol. 54, Núm. 2, pp. 321-327

  4. Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease

    American Journal of Gastroenterology, Vol. 104, Núm. 8, pp. 1968-1975

  5. Prevalence of Functional Gastrointestinal Disorders in Patients With Fibromyalgia and the Role of Psychologic Distress

    Clinical Gastroenterology and Hepatology, Vol. 7, Núm. 4, pp. 438-445

  6. Role of ATG16L1 Thr300Ala polymorphism in inflammatory bowel disease: A study in the spanish population and a meta-analysis

    Inflammatory Bowel Diseases, Vol. 15, Núm. 11, pp. 1697-1704

  7. Specific association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15- Crohn's disease patients

    European Journal of Human Genetics, Vol. 17, Núm. 10, pp. 1304-1308

2008

  1. "12 Weeks' stopping rule" in the treatment of genotype 1 chronic hepatitis C: Two prognostic categories under the same label?

    Scandinavian Journal of Gastroenterology, Vol. 43, Núm. 8, pp. 979-983

  2. Determinants of quality of life in irritable bowel syndrome

    Journal of Clinical Gastroenterology, Vol. 42, Núm. 9, pp. 1003-1009

  3. IL23R and IL12B polymorphisms in Spanish IBD patients: No evidence of interaction

    Inflammatory Bowel Diseases, Vol. 14, Núm. 9, pp. 1192-1196